As filed with the United States Securities and
Exchange Commission on November 19, 2021.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
GINKGO BIOWORKS HOLDINGS, INC.
(Exact Name of Registrant as Specified in Its
Charter)
|
|
|
Delaware |
|
87-2652913 |
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
27 Drydock Avenue
8th Floor
Boston, MA 02210
(877) 422-5362
(Address, Including Zip Code, and Telephone
Number, Including Area Code, of Registrant’s Principal Executive
Offices)
Ginkgo Bioworks Holdings, Inc. 2021 Incentive
Award Plan
Ginkgo Bioworks Holdings, Inc. 2021 Employee
Stock Purchase Plan
Ginkgo Bioworks, Inc. 2014 Stock Incentive
Plan
Ginkgo Bioworks, Inc. 2008 Stock Incentive
Plan
(Full title of the plan)
Mark Dmytruk
Chief Financial Officer
Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue
8th Floor
Boston, MA 02210
(877) 422-5362
(Name, Address, Including Zip Code, and Telephone
Number, Including Area Code, of Agent for Service)
Copies to:
Rachel W. Sheridan
Shagufa R. Hossain
Emily E. Taylor
Latham & Watkins LLP
555 Eleventh Avenue NW
Suite 1000
(202) 637-2200
Karen Tepichin
General Counsel
Ginkgo Bioworks Holdings, Inc.
27 Drdock Avenue
8th Floor
Boston, MA 02210
(877) 422-5362
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a smaller
reporting company or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company” and “emerging growth company” in Rule
12b-2 of the Exchange
Act:
|
|
|
|
|
|
|
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☒ |
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the
Securities Act ☐
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title of Each Class of
Securities to be Registered |
|
Amount
to be
Registered(1)
|
|
Proposed
Maximum
Offering Price
per Share
|
|
Proposed
Maximum
Aggregate
Offering Price
|
|
Amount of
Registration Fee
|
|
Ginkgo Bioworks Holdings, Inc. 2021 Incentive Award
Plan Class A common stock, par value $0.0001 per
share
|
|
200,440,957(2) |
|
$12.74(6) |
|
$2,553,617,792.18 |
|
$236,720.37 |
Class B common stock, par value $0.0001 per share
|
|
200,440,957(2) |
|
$12.74(6) |
|
$2,553,617,792.18 |
|
$236,720.37 |
Ginkgo Bioworks Holdings, Inc. 2021 Employee Stock
Purchase Plan
Class A common stock, par value $0.0001 per share
|
|
20,000,000(3) |
|
$12.74(6) |
|
$254,800,000 |
|
$23,619.96 |
Class B common stock, par value $0.0001 per share
|
|
20,000,000(3) |
|
$12.74(6) |
|
$254,800,000 |
|
$23,619.96 |
Ginkgo Bioworks, Inc. 2014 Stock Incentive Plan
Class A common stock, par value $0.0001 per share
|
|
286,833,305(4) |
|
$12.74(6) |
|
$3,654,256,305.70 |
|
$338,749.56 |
Class B common stock, par value $0.0001 per share
|
|
286,833,305 (4) |
|
$12.74(6) |
|
$3,654,256,305.70 |
|
$338,749.56 |
Ginkgo Bioworks, Inc. 2008 Stock Incentive Plan
Class A common stock, par value $0.0001 per share
|
|
30,495,320(5) |
|
$0.02(7) |
|
$609,906.40 |
|
$56.54 |
Class B common stock, par value $0.0001 per share
|
|
30,495,320(5) |
|
$0.02(7) |
|
$609,906.40 |
|
$56.54 |
TOTAL
|
|
1,075,539,164 |
|
— |
|
$12,926,568,008.56 |
|
$1,198,292.85 |
|
|
(1) |
Pursuant to Rule 416(a) of the Securities Act of 1933,
as amended (the “Securities Act”), this Registration
Statement also covers any additional shares of Class A common
stock, par value $0.0001 per share (the
“Class A Common Stock”), and
Class B common stock, par value $0.0001 per share (the
“Class B Common Stock”), of Ginkgo
Bioworks Holdings, Inc. (the “Registrant”) that
become issuable under the Ginkgo Bioworks Holdings, Inc. 2021
Incentive Award Plan (the “2021 Plan”), the Ginkgo
Bioworks, Inc. 2014 Stock Incentive Plan (the “2014
Plan”), the Ginkgo Bioworks, Inc. 2008 Stock Incentive Plan
(the “2008 Plan”) and the Ginkgo Bioworks Holdings,
Inc. Employee Stock Purchase Plan (the “ESPP”), as
applicable, by reason of any future share splits, share dividends,
recapitalizations or any other similar transactions effected
without the receipt of consideration by the Registrant, which
results in an increase in the number of outstanding shares of
Class A Common Stock or Class B Common Stock.
|
(2) |
Represents 200,440,957 shares reserved for future
issuance under the 2021 Plan. The shares authorized for issuance
under the 2021 Plan can be either in the form of Class A
Common Stock (that is convertible to Class B Common Stock on
a one-for-one basis)
or Class B Common Stock (that is convertible to Class A
Common Stock on a one-for-one basis),
as determined by the Registrant. As a result, we have registered
the maximum number of shares of Class A Common Stock and the
maximum number of Class B Common Stock that could be issued.
The total number of shares reserved for issuance under the 2021
Plan will automatically increase on the first day of each calendar
year, beginning with calendar year 2022, by a number of shares
equal to the lesser of (A) 4% of the total outstanding shares
of Class A Common Stock and Class B Common Stock on the
last day of the immediately preceding calendar year and
(B) such smaller number of shares as is determined by the
Registrant’s board of directors (the “Board”).
Additional shares related to such automatic increase have not been
included in this Registration Statement.
|
(3) |
Represents 20,000,000 shares reserved for future
issuance under the ESPP, which may be issued as Class A Common
Stock and/or Class B Common Stock. The shares authorized for
issuance under the ESPP can be either in the form of Class A
Common Stock (that is convertible to Class B Common Stock on
a one-for-one basis)
or Class B Common Stock (that is convertible to Class A
Common Stock on a one-for-one basis),
as determined by the Registrant. The total number of shares
reserved for issuance under the ESPP will automatically increase on
the first day of each calendar year, beginning with calendar year
2022, by a number of shares equal to the lesser of (A) 1% of
the total number of outstanding shares of Class A Common Stock
on the last day of the immediately preceding calendar year and
(B) such smaller number of shares as is determined by the
Board. Additional shares related to such automatic increase have
not been included in this Registration Statement.
|
(4) |
Represents 286,833,305 shares subject to outstanding
awards under the 2014 Plan as of September 16, 2021. To the
extent that (i) awards outstanding under the 2014 Plan expire,
lapse or are terminated, exchanged for or settled in cash,
surrendered, repurchased, cancelled or forfeited or
(ii) shares subject to outstanding 2014 Plan awards are
delivered to the Registrant to satisfy the applicable exercise or
purchase price of an award and/or any applicable tax withholding
obligation with respect to the award, the shares of Class A
Common Stock or Class B Common Stock, as applicable, subject
to the awards will be available for future issuance under the 2021
Plan. The shares issuable under the 2014 Plan can be either in the
form of Class A Common Stock (that is convertible to
Class B Common Stock on a one-for-one basis)
or Class B Common Stock (that is convertible to Class A
Common Stock on a one-for-one basis),
as determined by the Registrant. As a result, we have registered
the maximum number of shares of Class A Common Stock and the
maximum number of Class B Common Stock that could be
issued.
|
(5) |
Represents 30,495,320 shares subject to outstanding
awards under the 2008 Plan as of September 16, 2021. To the
extent that (i) awards outstanding under the 2008 Plan expire,
lapse or are terminated, exchanged for or settled in cash,
surrendered, repurchased, cancelled or forfeited or
(ii) shares subject to outstanding 2008 Plan awards are
delivered to the Registrant to satisfy the applicable exercise or
purchase price of an award and/or any applicable tax withholding
obligation with respect to the award, the shares of Class A
Common Stock or Class B Common Stock, as applicable subject to
the awards will be available for future issuance under the 2021
Plan. The shares issuable under the 2008 Plan can be either in the
form of Class A Common Stock (that is convertible to
Class B Common Stock on a one-for-one basis)
or Class B Common Stock (that is convertible to Class A
Common Stock on a one-for-one basis),
as determined by the Registrant. As a result, we have registered
the maximum number of shares of Class A Common Stock and the
maximum number of Class B Common Stock that could be
issued.
|
(6) |
Estimated solely for the purpose of calculating the
registration fee in accordance with Rule 457(c) and Rule 457(h)(1)
of the Securities Act based on the average of the high and low
prices of a share of the Registrant’s Class A Common Stock on
the New York Stock Exchange on November 15, 2021.
|
(7) |
Estimated solely for the purpose of calculating the
registration fee in accordance with Rule 457(h) of the Securities
Act, based on the weighted-average exercise price of previously
granted stock options that remain outstanding under the 2008 Plan
($0.02 per share).
|